Sponsored
Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small molecule APIs to advance biocatalysis across pharma.
Mandy Vink
Advertisement
Articles by Mandy Vink
Advertisement
Latest Updated Articles
How Codexis is Redefining Pharma BiocatalysisPublished: December 18th 2025 | Updated: January 14th 2026
- How Codexis is Redefining Pharma Biocatalysis
Published: December 18th 2025 | Updated: January 14th 2026
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
2
Our Biggest Takeaways From AAPS PharmSci 360
3
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
4
Choosing a Connected Product Technology for Anticounterfeiting
5